Is Trientine available in China?
Trientine (Trientine) is a drug mainly used to treat Wilson's disease. Wilson's disease is a hereditary disease. Abnormal copper metabolism in the patient's body leads to excessive accumulation of copper in the liver and other tissues, which in turn causes a series of health problems. As a copper chelator, trientine binds to excess copper in the body, thereby promoting its excretion, helping to reduce copper concentrations in the body, reducing symptoms caused by Wilson's disease and preventing further tissue damage.
The indications for trientine focus on the treatment of patients with established Wilson's disease, particularly those who experience adverse reactions to or are intolerant to penicillamine (another commonly used drug for the treatment of Wilson's disease). In addition, trientine may also be used in certain cases of copper accumulation diseases. Specific use must be followed under the guidance of a doctor.
in the country, the listing status of trientine is relatively special. According to information in November 2023, Qu Enting entered the market through the franchise policy of Hainan Boao Lecheng International Medical Tourism Pilot Zone. This policy aims to promote medical innovation and the introduction of new drugs so that patients can obtain more advanced treatment options. However, since the purchase channels for this drug are subject to certain restrictions, consumers need to pay attention to relevant policy information and approval procedures when obtaining the drug.
At present, the specific sales channels of Trientine in China are not yet widespread, and are mainly concentrated in specific regions and approved medical institutions. If patients need to purchase trientine, it is recommended that they first consult a doctor or go to a compliant medical institution for consultation to obtain the latest drug information and purchase channels. In addition, the price of medicines may also vary from different channels. Before deciding to purchase medicines, it is best for patients to understand the relevant costs in order to make a reasonable budget.
Reference:https://reference.medscape.com/drug/cuvrior-syprine-trientine-342888
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)